On March 31, 2026, Oncotelic Therapeutics, Inc. entered into a Joint Development, Manufacturing, and Licensing Agreement with TechForce Robotics, Inc. This agreement establishes a framework for the joint development and manufacturing of AI-enabled robotic systems for pharmaceutical environments. It includes a non-exclusive license of certain company intellectual property.
Company Information
Company
Oncotelic Therapeutics
Location
Agoura Hills, California, United States
About
Oncotelic Therapeutics, Inc. is focused on developing innovative therapies for cancer treatment, primarily through the use of immunotherapy. The company's key products include novel therapeutic agents designed to enhance the immune response against tumor cells, with a particular emphasis on maximizing patient outcomes in oncology. Its operations are primarily based in the United States, with plans to explore global markets for its therapies. As a mid-sized biopharmaceutical company, Oncotelic is actively involved in clinical trials and research initiatives aimed at advancing its drug pipeline and expanding its therapeutic reach.
Agoura HillsBiotechnologyHealthcareHealth CareTherapeutics